Works matching IS 00070920 AND DT 2018 AND VI 119 AND IP 10


Results: 15
    1
    2
    3
    4
    5
    6

    A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours.

    Published in:
    2018
    By:
    • Maity, Amit;
    • Mick, Rosemarie;
    • Huang, Alexander C.;
    • George, Sangeeth M.;
    • Farwell, Michael D.;
    • Lukens, John N.;
    • Berman, Abigail T.;
    • Mitchell, Tara C.;
    • Bauml, Josh;
    • Schuchter, Lynn M.;
    • O’Hara, Mark;
    • Lin, Lilie L.;
    • Demichele, Angela;
    • Christodouleas, John P.;
    • Haas, Naomi B.;
    • Patsch, Dana M.;
    • Hahn, Stephen M.;
    • Minn, Andy J.;
    • Wherry, E. John;
    • Vonderheide, Robert H.
    Publication type:
    journal article
    7
    8
    9
    10

    pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry.

    Published in:
    2018
    By:
    • Jones, Gemma N.;
    • Rooney, Claire;
    • Griffin, Nicola;
    • Roudier, Martine;
    • Young, Lucy A.;
    • Garcia-Trinidad, Antonio;
    • Hughes, Gareth D.;
    • Whiteaker, Jeffrey R.;
    • Wilson, Zena;
    • Odedra, Rajesh;
    • Zhao, Lei;
    • Ivey, Richard G.;
    • Howat, William J.;
    • Harrington, Elizabeth A.;
    • Barrett, J. Carl;
    • Ramos-Montoya, Antonio;
    • Lau, Alan;
    • Paulovich, Amanda G.;
    • Cadogan, Elaine B.;
    • Pierce, Andrew J.
    Publication type:
    journal article
    11
    12
    13
    14
    15